InvestorsHub Logo

GoodGuyBill

09/12/19 1:57 AM

#243820 RE: AngeloFoca #243819

Merc may have to buy NWBO for $50-$75 billion to stop the DCVax-L + Direct combo from killing Keytruda?

pgsd

09/12/19 2:35 AM

#243824 RE: AngeloFoca #243819

I cannot blame him lol

erik007tc

09/12/19 7:37 AM

#243830 RE: AngeloFoca #243819

So Merck will partner with nwbo because they want keytruda/dcvax-L combo. Then will also fund the trials for direct, so instead of an nwbo buyout upfront they first want Dr Duffy to scope and diagnose it all out and then once all are in order they’ll execute the negotiated LP’s buyout price, which will be the maximum value of nwbo $50+


jondoeuk

09/12/19 10:57 AM

#243861 RE: AngeloFoca #243819

''Dear god... he certainly seems to be zeroing in on DC Vax.''

MRK is already testing two personalised vaccines and four intratumoral based therapies (CVA21 can also be given via IV).


flipper44

09/12/19 12:46 PM

#243888 RE: AngeloFoca #243819

Ten seconds. Listen to what you can do with the right optimization to address the correct type of tumor you want to fight. 3:04 to 3:14.

https://nwbio.com/update-on-dc-vax-at-asco-2019/